IRCT20190701044062N3招募中3 期
comparison the teraputic effect of pioglitazone and carnitine to metformin and carnitine in patients with non alcoholic fatty liver disease
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 17 years 至 50 years（—）
- 性别
- All
入选标准
- •17-50 years old
- •Paitents with non alcoholic fatty liver disease who have been ruled out all known causes of fatty liver disease including alcohol, medications, viral hepatitis, autoimmune hepatitis and metabolic causes such as Wilson and hemochromatosis and etc.
排除标准
- •Patients with liver disease such as viral hepatitis, autoimmune hepatitis, Wilson, hemochromatosis, liver cirrhosis, and PBC and PSC
- •Patients who drink alcohol.
- •Patients with renal Failure ( Creatinine > 1.5 mg/dl)
- •Patients with known severe systemic disease and malignancy.
- •Pregnancy or breastfeeding
- •Patients with type 1 diabetes
研究者
相似试验
已完成
3 期
comparison the therapeutic effect of pioglitazone and carnitine to pioglitazone and vitamin E in patients with non alcoholic fatty liver diseaseIRCT20190701044062N8Tabriz University of Medical Sciences80
已完成
2 期
Comparison the treatment effect of Pioglithazone with Metformin in patients withNon Alcoholic SteatoHepatitis (NASH)Fatty liver.fatty (change of) liver, not elsewhere classifiedIRCT201105026361N1Vice chancellor for research, Kashan University of Medical Sciences and Health Services80
招募中
3 期
Effect of Pioglitazone and ClobetasolIRCT20210926052596N1Tehran University of Medical Sciences40
已完成
3 期
Effect of metformin and pioglitazon in treatment of fatty liverIRCT20150706023083N2Tabriz University of Medical Sciences68
招募中
3 期
Therapy of non alcoholic fatty liver diseaseIRCT20211014052767N1Oroumia University of Medical Sciences110